SKYRIZI 600 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
SKYRIZI 600 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Commercialized
Register Number
1191361004
Prescription Type
Uso Hospitalario
Authorization Date
Dec 15, 2022
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1191361004
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
RISANKIZUMABActive
Quantity: 600 mg
Name: RISANKIZUMAB
ATC CLASSIFICATION (3)
L04A
L04AC
L04AC18